Clinical Study Site

Cincinnati, Ohio 45229

3 studies enrolling now · 7 studies all time

What they study most

Bleeding, C3 Glomerulonephritis, C3 Glomerulopathy, Chronic Inflammatory Demyelinating Polyneuropathy, Dense Deposit Disease, Fabry Disease, IC-MPGN, Immune Complex Membranoproliferative Glomerulonephritis, Metastatic Colorectal Cancer (CRC), Multifocal Motor Neuropathy, Myasthenia Gravis, Generalized

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) — Recruiting now
• A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy — Recruiting now
• A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) — Running, not enrolling
• A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471 — Stopped early
• A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study) — Completed
• Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years) — Completed